Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Sickle Cell Anemia Testing & Screening market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Sickle Cell Anemia Testing & Screening market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
The Sickle Cell Anemia Testing & Screening market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Sickle Cell Anemia Testing & Screening products across developed and developing countries of the world.
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Sickle Cell Anemia Testing & Screening products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Sickle Cell Anemia Testing & Screening market.
To learn more about this report
Increasing research and development spending on Sickle Cell Anemia Testing & Screening development has been the leading industry trend of Sickle Cell Anemia Testing & Screening market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
To learn more about this report
| Report Attributes | Details |
| The market size value in 2021 | USD XX.XX Million |
| CAGR (2021 - 2028) | XX.XX % |
| The Revenue forecast in 2028 | USD XX.XX Million |
| Base year for estimation | 2021 |
| Historical data | 2018-2019 |
| Forecast period | 2022-2028 |
| Quantitative units |
|
| Report coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered | By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook | Hemoglobin Electrophoresis, High-performance Liquid Chromatography (HPLC), Point-of-Care Tests, Other Tests |
| By Application Outlook | Newborn Screening (12 months and below), Adult Screening (25 to 60 years), Other Age Groups (1 to 25 & above 60 years) |
| Regional scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope | U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled | STRECK, INC., Daktari Diagnostics, BIOMEDOMICS INC., Laboratory Corporation of America Holdings, Request A Test, Ltd., HALCYON BIOMEDICAL INCORPORATED, Silver Lake Research Corporation, HEMOTYPE, HEMEX HEALTH, Bio-Rad Laboratories, Inc., PerkinElmer Inc., Quest Diagnostics |
| Customization Available | Yes, the report can be tailored to meet your specific requirements. |
1 Methodology and Scope
1.1 Market segmentation & scope
1.2 Information Procurement
1.2.1 Purchased Database
1.2.2 Eternity’s Internal Database
1.2.3 Secondary sources & third-party perspectives
1.2.4 Primary Research
1.3 Information analysis
1.4 Market formulation & data visualization
1.5 Data validation & publishing
2 Executive Summary
3 Sickle Cell Anemia Testing & Screening Market Variables, Trends & Scope
3.1 Market Dynamics
3.1.1 Market Driver Analysis
3.1.2 Market Restraints
3.1.3 Market Challenge Analysis
3.1.4 Market Opportunities
3.1.5 Micro & Macro Indicator
3.2 Impact of COVID-19 Pandemic on Global Sickle Cell Anemia Testing & Screening Market
3.2.1 Overview of Changing Landscape
3.2.2 Pre-covid & Post-Covid Market Analysis
3.3 Market Attractiveness Analysis
3.4 Regulatory Scenario
3.5 Industry Trend Analysis- Historic and Future Trend Assessment
3.6 Merger & Acquisition
3.7 New System Launch/Approvals
3.8 Market Analysis Tools
3.8.1 Porter’s Five Forces
3.8.2 PEST Analysis
3.8.3 Value Chain Analysis
3.9 Key Company Ranking Analysis, 2020
4 Global Sickle Cell Anemia Testing & Screening Market Analysis and Forecast, By Type
4.1 Overview & Definition
4.2 Key Trends
4.3 Global Sickle Cell Anemia Testing & Screening Market Value (US$ Mn) Forecast, by Type (2019 – 2028)
4.2.1 Hemoglobin Electrophoresis
4.2.2 High-performance Liquid Chromatography (HPLC)
4.2.3 Point-of-Care Tests
4.2.4 Other Tests
4.4 Type Comparison Matrix
4.5 Global Sickle Cell Anemia Testing & Screening Market Attractiveness, By Type
5 Global Sickle Cell Anemia Testing & Screening Market Analysis and Forecast, By Application
5.1 Overview & Definition
5.2 Key Trends
5.3 Global Sickle Cell Anemia Testing & Screening Market Value (US$ Mn) Forecast, by Application (2019 – 2028)
5.3.1 Newborn Screening (12 months and below)
5.3.2 Adult Screening (25 to 60 years)
5.3.3 Other Age Groups (1 to 25 & above 60 years)
5.4 Application Comparison Matrix
5.5 Global Sickle Cell Anemia Testing & Screening Market Attractiveness, by Application
6 Global Sickle Cell Anemia Testing & Screening Market Analysis and Forecast, By Region
6.1 Overview & Definition
6.2 Key Trends
6.3 Global Sickle Cell Anemia Testing & Screening Market Value (US$ Mn) Forecast, by Region (2019 – 2028)
6.4 North America
6.5 Europe
6.6 Asia Pacific
6.7 Latin America
6.8 Middle East & Africa
7 Global Sickle Cell Anemia Testing & Screening Market Attractiveness, by Region
8 North America Sickle Cell Anemia Testing & Screening Market Analysis and Forecast
8.1 Key Findings
8.2 North America Sickle Cell Anemia Testing & Screening Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
8.2.1 Hemoglobin Electrophoresis
8.2.2 High-performance Liquid Chromatography (HPLC)
8.2.3 Point-of-Care Tests
8.2.4 Other Tests
8.3 North America Sickle Cell Anemia Testing & Screening Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
8.3.1 Newborn Screening (12 months and below)
8.3.2 Adult Screening (25 to 60 years)
8.3.3 Other Age Groups (1 to 25 & above 60 years)
8.4 North America Sickle Cell Anemia Testing & Screening Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
8.4.1 U.S.
8.4.2 Canada
8.4.3 Rest of North America
8.5 North America Sickle Cell Anemia Testing & Screening Market Attractiveness Analysis
8.5.1 By Type
8.5.2 By Application
8.5.3 By Country
9 Europe Sickle Cell Anemia Testing & Screening Market Analysis and Forecast
9.1 Key Findings
9.2 Europe Sickle Cell Anemia Testing & Screening Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
9.2.1 Hemoglobin Electrophoresis
9.2.2 High-performance Liquid Chromatography (HPLC)
9.2.3 Point-of-Care Tests
9.2.4 Other Tests
9.3 Europe Sickle Cell Anemia Testing & Screening Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
9.3.1 Newborn Screening (12 months and below)
9.3.2 Adult Screening (25 to 60 years)
9.3.3 Other Age Groups (1 to 25 & above 60 years)
9.4 Europe Sickle Cell Anemia Testing & Screening Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
9.4.1 U.K.
9.4.2 Germany
9.4.3 France
9.4.4 Italy
9.4.5 Rest of Europe
9.5 Europe Sickle Cell Anemia Testing & Screening Market Attractiveness Analysis
9.5.1 By Type
9.5.2 By Application
9.5.3 By Country
10 Asia Pacific Sickle Cell Anemia Testing & Screening Market Analysis and Forecast
10.1 Key Findings
10.2 Asia Pacific Sickle Cell Anemia Testing & Screening Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
10.2.1 Hemoglobin Electrophoresis
10.2.2 High-performance Liquid Chromatography (HPLC)
10.2.3 Point-of-Care Tests
10.2.4 Other Tests
10.3 Asia Pacific Sickle Cell Anemia Testing & Screening Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
10.3.1 Newborn Screening (12 months and below)
10.3.2 Adult Screening (25 to 60 years)
10.3.3 Other Age Groups (1 to 25 & above 60 years)
10.4 Asia Pacific Sickle Cell Anemia Testing & Screening Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
10.4.1 China
10.4.2 India
10.4.3 Japan
10.4.4 South Korea
10.4.5 Rest of APAC
10.5 Asia Pacific Sickle Cell Anemia Testing & Screening Market Attractiveness Analysis
10.5.1 By Type
10.5.2 By Application
10.5.3 By Country
11 Latin America Sickle Cell Anemia Testing & Screening Market Analysis and Forecast
11.1 Key Findings
11.2 Latin America Sickle Cell Anemia Testing & Screening Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
11.2.1 Hemoglobin Electrophoresis
11.2.2 High-performance Liquid Chromatography (HPLC)
11.2.3 Point-of-Care Tests
11.2.4 Other Tests
11.3 Latin America Sickle Cell Anemia Testing & Screening Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
11.3.1 Newborn Screening (12 months and below)
11.3.2 Adult Screening (25 to 60 years)
11.3.3 Other Age Groups (1 to 25 & above 60 years)
11.4 Latin America Sickle Cell Anemia Testing & Screening Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
11.4.1 Brazil
11.4.2 Rest of Latin America China
11.5 Latin America Sickle Cell Anemia Testing & Screening Market Attractiveness Analysis
11.5.1 By Type
11.5.2 By Application
11.5.3 By Country
12 Middle East & Africa (MEA) Sickle Cell Anemia Testing & Screening Market Analysis and Forecast
12.1 Key Findings
12.2 Middle East & Africa (MEA) Sickle Cell Anemia Testing & Screening Market Analysis (US$ Mn) and Forecast, By Product Type (2019-2028)
12.2.1 Hemoglobin Electrophoresis
12.2.2 High-performance Liquid Chromatography (HPLC)
12.2.3 Point-of-Care Tests
12.2.4 Other Tests
12.3 Middle East & Africa (MEA) Sickle Cell Anemia Testing & Screening Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
12.3.1 Newborn Screening (12 months and below)
12.3.2 Adult Screening (25 to 60 years)
12.3.3 Other Age Groups (1 to 25 & above 60 years)
12.4 Middle East & Africa (MEA) Sickle Cell Anemia Testing & Screening Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
12.4.1 GCC Countries
12.4.2 South Africa
12.4.3 Rest of MEA
12.5 Middle East & Africa (MEA) Sickle Cell Anemia Testing & Screening Market Attractiveness Analysis
12.5.1 By Type
12.5.2 By Application
12.5.3 By Country
13 Competitive Landscape
13.1 Market Players – Competition Matrix
13.2 Market Share Analysis by Key Players, 2020 (%)
13.3 Company Profiles
13.3.1 STRECK
13.3.1.1 Company Overview
13.3.1.2 Company Snapshot
13.3.1.3 Financial Overview
13.3.1.4 Product Portfolio
13.3.1.5 Key Developments/Strategies
13.3.2 INC.
13.3.3 Daktari Diagnostics
13.3.4 BIOMEDOMICS INC.
13.3.5 Laboratory Corporation of America Holdings
13.3.6 Request A Test
13.3.7 Ltd.
13.3.8 HALCYON BIOMEDICAL INCORPORATED
13.3.9 Silver Lake Research Corporation
13.3.10 HEMOTYPE
13.3.11 HEMEX HEALTH
13.3.12 Bio-Rad Laboratories
13.3.13 Inc.
13.3.14 PerkinElmer Inc.
13.3.15 Quest Diagnostics
14 Key Takeaways
Choose License Type